Literature DB >> 19945134

Overexpression of Toll-like receptor 2/4 on monocytes modulates the activities of CD4(+)CD25(+) regulatory T cells in chronic hepatitis B virus infection.

Ye Zhang1, Jian-Qi Lian, Chang-Xing Huang, Jiu-Ping Wang, Xin Wei, Xue-Ping Nan, Hai-Tao Yu, Li-Li Jiang, Xiao-Qin Wang, Yan Zhuang, Xin-Hong Li, Yu Li, Ping-Zhong Wang, Michael D Robek, Xue-Fan Bai.   

Abstract

The significance of TLR expression and Tregs in HBV infection has not been clearly described. In this report, flow cytometry was performed to assess TLR2/4 expression on monocytes and circulating CD4(+)CD25(+)CD127(low/-) Tregs frequency of 16 acute hepatitis B (AHB), 42 chronic hepatitis B (CHB), 22 asymptomatic HBV carriers (AsC), and 20 normal controls (NC). We found that TLR2 and TLR4 were overexpressed on CD14(+) monocytes in HBV-infected patients as compared with NCs. Upregulation of TLR2 in NCs and TLR4 in CHBs was observed following HBeAg incubation. However, TLR2 and TLR4 expression decreased after HBcAg stimulation. The difference in the proportion of Tregs between NCs and CHBs was significant. Both Pam3Csk4 (TLR2 agonist)- and lipopolysaccharide (TLR4 agonist)-activated CD4(+)CD25(+) Tregs showed enhanced suppression function in CHBs. These results suggest that overexpression of TLR2 and TLR4 may modulate the suppressive function of Tregs, which contribute to the immunotolerance of chronic HBV infection. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945134     DOI: 10.1016/j.virol.2009.11.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

Review 1.  Recent insights into the role of Toll-like receptors in viral infection.

Authors:  M Carty; A G Bowie
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

2.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

3.  Relationship between expression of toll-like receptors 2/4 in dendritic cells and chronic hepatitis B virus infection.

Authors:  Xiaobo Lu; Qi Xu; Xianyu Bu; Xiuming Ma; Fengbo Zhang; Qiang Deng; Yuexin Zhang; Jianbing Ding
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Cutaneous RANK-RANKL Signaling Upregulates CD8-Mediated Antiviral Immunity during Herpes simplex Virus Infection by Preventing Virus-Induced Langerhans Cell Apoptosis.

Authors:  Lars Klenner; Wali Hafezi; Björn E Clausen; Eva U Lorentzen; Thomas A Luger; Stefan Beissert; Joachim E Kühn; Karin Loser
Journal:  J Invest Dermatol       Date:  2015-06-15       Impact factor: 8.551

5.  Opisthorchis viverrini excretory/secretory products induce toll-like receptor 4 upregulation and production of interleukin 6 and 8 in cholangiocyte.

Authors:  Kantima Ninlawan; Steve P O'Hara; Patrick L Splinter; Puangrat Yongvanit; Sasithorn Kaewkes; Arpa Surapaitoon; Nicholas F LaRusso; Banchob Sripa
Journal:  Parasitol Int       Date:  2010-09-29       Impact factor: 2.230

6.  Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.

Authors:  Xue-Ping Nan; Ye Zhang; Hai-Tao Yu; Rui-Lin Sun; Mei-Juan Peng; Yu Li; Wen-Jing Su; Jian-Qi Lian; Jiu-Ping Wang; Xue-Fan Bai
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

Review 7.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells.

Authors:  Ying-Ju Li; Ping Zhu; Yu Liang; Wei-Guo Yin; Jian-Hua Xiao
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

9.  Toll-like receptor 2 promotes T helper 17 cells response in hepatitis B virus infection.

Authors:  Rong-Rong Zhao; Xiao-Fei Yang; Jie Dong; Yan-Yan Zhao; Xin Wei; Chang-Xing Huang; Jian-Qi Lian; Ye Zhang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

10.  A fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice.

Authors:  Ye Zhang; Wen-Jing Su; Jue Wang; Xue-Fan Bai; Chang-Xing Huang; Jian-Qi Lian
Journal:  Viral Immunol       Date:  2014-09-11       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.